A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Patients With Manifest Huntington's Disease
Neurodegenerative Disorder Huntington Disease (HD)
For the latest version of this information please go to www.forpatients.roche.com